BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Shukra Pharmaceuticals Ltd Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
524632
ISIN Demat
INE551C01044
Book Value (Rs)
2.1836772
NSE Symbol
SHUKRAPHAR
Divident Yield %
0.02
Market Cap
(Rs In Cr.)
1,939
P/E (TTM)
53.79
EPS (TTM)
0.82
Face Value
(Rs)
1
Back
Shukra Pharmaceuticals consolidated net profit rises 1158.25% in the June 2026 quarter
12-Aug-26   Hrs IST

Net profit of Shukra Pharmaceuticals rose 1158.25% to Rs 12.96 crore in the quarter ended June 2026 as against Rs 1.03 crore during the previous quarter ended June 2025. Sales rose 336.36% to Rs 23.52 crore in the quarter ended June 2026 as against Rs 5.39 crore during the previous quarter ended June 2025.

ParticularsQuarter Ended
Jun. 2026Jun. 2025% Var.
Sales23.525.39 336
OPM %81.3824.49 -
PBDT19.252.16 791
PBT18.171.37 1226
NP12.961.03 1158

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)